QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Quantum Biopharma Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026
$2.41−0.06 (-2.43%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Quantum Biopharma statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Market Cap | $9.37M | $166.30M |
| Enterprise Value | $3.87M | $88.19M |
| PB Ratio | 1.18 | 2.03 |
| P/TBV Ratio | 2.57 | 2.29 |
Income (trailing twelve months)
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Operating Income | -$15.30M | -$21.40M |
| EBITDA | -$14.76M | -$16.91M |
Returns
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Return on Invested Capital (ROIC) | -368.1% | -32.4% |
| Return on Capital Employed (ROCE) | -251.1% | -38.1% |
Balance sheet
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.65M | $61.43M |
| Net Cash (Debt) | $3.65M | $15.35M |
| Net Cash Per Share | $0.94 | $0.66 |
| Equity (Book Value) | $7.95M | $49.09M |
| Book Value Per Share | $2.04 | $1.37 |
| Tangible Book Value | $3.64M | $23.52M |
| Working Capital | $1.66M | $76.81M |
Financial position
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Current Ratio | 1.20 | 3.34 |
| Quick Ratio | 0.44 | 2.44 |
| Interest Coverage | -96.81 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$8.24M | -$12.35M |
Efficiency
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Employee Count | 7 | 74 |
Dividends and yields
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Buyback Yield | -3.61% | -0.59% |
| Shareholder Yield | -3.61% | 0.00% |
Shares
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Shares Outstanding | 3,887,770 | 58,127,000 |
| Float | 3,887,770 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
| Shares Held by Institutions | 10.7% | 59.4% |
Scores
| Measure | Quantum Biopharma | Industry median |
|---|---|---|
| Altman Z-Score | -23.62 | -0.22 |
Calculated by StockData from Quantum Biopharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.